Corporate Banner
Satellite Banner
Scientific Community
Join | Sign in

  News Archive

Researcher Discovers Molecules That Kill Cancer, Protect Healthy Cells
Thursday, May 14, 2015
This research shines a light on what happens to cells at the moment they become cancerous and the potential of femtomedicine to revolutionize cancer treatment.

Lilly and BioNTech Announce Research Collaboration
Wednesday, May 13, 2015
Research collaboration to discover novel cancer immunotherapies.

TxCell Presents Positive Results for Col-Treg
Tuesday, May 12, 2015
Company presents results in a model of autoimmune uveitis at 2015 ARVO Annual Meeting, Denver, Colorado, US.

Foreign Antibodies Mobilize Immune System to Fight Cancer
Thursday, May 07, 2015
A mouse’s T cells can be primed to attack and eliminate a malignant tumor by injecting antibodies from another mouse with resistance to the tumor, as well as by activating certain signaling cells, a study has found.

arGEN-X Announces Publication on Therapeutic Potential of Antibody ARGX-115
Friday, May 01, 2015
Results on ARGX-115 published in Science Translational Medicine indicating inhibition of immune checkpoint GARP in in vivo mouse model.

Id1 Gene Interferes With Immune System
Thursday, April 30, 2015
Uncovering new functions of a gene implicated in cancer growth opens new therapeutic possibilities.

Gene Variants Show Potential In Predicting Rheumatoid Arthritis Disease Outcomes
Thursday, April 30, 2015
Arthritis Research UK-funded scientists at The University of Manchester have identified a new way in which genotyping can be used to predict disease outcomes among sufferers of rheumatoid arthritis.

Microneedle Patch For Measles Vaccination Could Be A Global Game Changer
Wednesday, April 29, 2015
A new microneedle patch being developed by the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) could make it easier to vaccinate people against measles and other vaccine-preventable diseases.

TetraLogic and Merck to Collaborate
Friday, April 24, 2015
Collaboration on the evaluation of birinapant in combination with KEYTRUDA® (pembrolizumab) in solid tumors.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1462

SELECTBIO Market Reports
Go to LabTube
Go to eposters